Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
Carregando...
Citações na Scopus
36
Tipo de produção
article
Data de publicação
2014
Editora
HINDAWI PUBLISHING CORPORATION
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
BIOMED RESEARCH INTERNATIONAL, article ID 106247, 6p, 2014
Resumo
Hepatocellular carcinoma (HCC) incidence is increasing worldwide in recent years. Most HCC cases develop in the presence of advanced chronic liver disease related to chronic hepatitis C virus (HCV) infection, chronic hepatitis B (HBV) infection, and alcohol abuse. Approximately 15-50% of HCC cases are classified as idiopathic, suggesting that other risk factors are responsible for its rising incidence. Recent studies suggest that nonalcoholic fatty liver disease (NAFLD) can be associated with these ""idiopathic"" cases. NAFLD progresses slowly and can develop into liver cirrhosis, liver failure, and HCC. In the last few years, NAFLD has received more attention because of its high prevalence worldwide.
Palavras-chave
Referências
- Adams LA, 2005, GASTROENTEROLOGY, V129, P113, DOI 10.1053/j.gastro.2005.04.014
- Ascha MS, 2010, HEPATOLOGY, V51, P1972, DOI 10.1002/hep.23527
- Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep20933
- Bugianesi E, 2002, GASTROENTEROLOGY, V123, P134, DOI 10.1053/gast.2002.34168
- Bugianesi E, 2007, Clin Liver Dis, V11, P191, DOI 10.1016/j.cld.2007.02.006
- Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423
- CANMAN CE, 1995, SEMIN CANCER BIOL, V6, P17, DOI 10.1006/scbi.1995.0003
- Chagas AL, 2009, BRAZ J MED BIOL RES, V42, P958, DOI 10.1590/S0100-879X2009005000019
- Davila JA, 2005, GUT, V54, P533, DOI 10.1136/gut.2004.052167
- de Lima VM, 2008, J HEPATOL, V49, P1055, DOI 10.1016/j.jhep.2008.07.024
- El-Serag HB, 2004, GASTROENTEROLOGY, V127, pS27, DOI 10.1053/j.gastro.2004.09.013
- El-Serag HB, 2004, GASTROENTEROLOGY, V126, P460, DOI 10.1053/j.gastro.2003.10.065
- Harrison SA, 2003, AM J GASTROENTEROL, V98, P2042, DOI 10.1016/S0002-9270(03)00622-1
- Hashimoto E, 2009, J GASTROENTEROL, V44, P89, DOI 10.1007/s00535-008-2262-x
- Hoshida Y, 2012, CURR CANCER DRUG TAR, V12, P1129
- Hu WW, 2002, CARCINOGENESIS, V23, P1781, DOI 10.1093/carcin/23.11.1781
- International Agency for Research on Cancer, 2002, IARC HDB CANC PREV
- Kahn C. R., 1995, ENDOCRINOLOGY, P1373
- KASAI H, 1989, CANCER RES, V49, P2603
- Kim H, 2004, J HEPATOL, V40, P298, DOI 10.1016/j.jhep.2003.10.023
- Kodama K, 2013, ALCOHOL CLIN EXP RES, V37, pE247, DOI 10.1111/j.1530-0277.2012.01900.x
- Kubrusly MS, 2010, HISTOL HISTOPATHOL, V25, P1123
- Leclerq I. A., 2000, HEPATOLOGY, V32
- Li Xiao, 2005, Hepatobiliary Pancreat Dis Int, V4, P427
- Marrero JA, 2002, HEPATOLOGY, V36, P1349, DOI 10.1053/jhep.2002.36939
- McCullough Arthur J, 2004, Clin Liver Dis, V8, P521, DOI 10.1016/j.cld.2004.04.004
- Mokdad AH, 2003, JAMA-J AM MED ASSOC, V289, P76, DOI 10.1001/jama.289.1.76
- Nair S, 2002, HEPATOLOGY, V36, P150, DOI 10.1053/jhep.2002.33713
- Parkin DM, 2001, INT J CANCER, V94, P153, DOI 10.1002/ijc.1440
- Pitot HC, 2001, LANCET, V358, P859, DOI 10.1016/S0140-6736(01)06038-X
- Roskams T, 2003, AM J PATHOL, V163, P1301, DOI 10.1016/S0002-9440(10)63489-X
- Sato W, 2006, HEPATOL RES, V34, P256, DOI 10.1016/j.hepres.2006.01.003
- Stefano JT, 2011, LIVER INT, V31, P377, DOI 10.1111/j.1478-3231.2010.02370.x
- Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360
- Yang ShiQi, 2001, Cancer Research, V61, P5016
- Zumoff B., 1988, ACTA MED SCAND, V223, P153